Initial Treatments and Responses for 51 Patients
| No. of patients with following response to initial treatment: | |||||
| Initial treatment | No. of patients | Complete remission | Partial remission | Progressive disease | No. of patients with recurrent disease* |
| Group 1 | |||||
| TTx + RAI | 17 | 14 | 3 | 0 | 0 |
| TTX + CLND + RAI | 23 | 12 | 10 | 1 | 5 |
| TTx + CLND + EBRT + RAI | 1 | 1 | 0 | 0 | 1 |
| TTx + MLND + RAI | 1 | 1 | 0 | 0 | 0 |
| TTx + CLND + MLND + RAI | 4 | 3 | 1 | 0 | 0 |
| Total | 46 | 31 | 14 | 1 | 6 |
| Group 2 | |||||
| TTx + CLND | 2 | 2 | 0 | 0 | 2 |
| Group 3 | |||||
| STTx | |||||
| LO + CLND + MLND | 1 | 1 | 0 | 0 | 1 |
| TUM | 1 | 1 | 0 | 0 | 1 |
| PT | 1 | 1 | 0 | 0 | 1 |
| Total | 3 | 3 | 0 | 0 | 3 |
↵* Recurrent disease was disease appearing during follow-up, after remission was achieved in patients who were treated with TTx and RAI or after several years in patients who underwent less intensive initial treatment (TTx or STTx).
LO = lobectomy; TUM = tumorectomy; PT = partial thyroidectomy.